Literature DB >> 2281040

Microdialysis sampling for determination of plasma protein binding of drugs.

A M Herrera1, D O Scott, C E Lunte.   

Abstract

The use of microdialysis sampling to study the binding of drugs to plasma proteins was evaluated. Microdialysis sampling is accomplished by placing a short length of dialysis fiber in the sample and perfusing the fiber with a vehicle. Small molecules in the sample, such as drugs, diffuse into the fiber and are transported to collection vials for analysis. Larger molecules, such as proteins and protein-bound drugs are excluded by the dialysis membrane. Microdialysis was found to give values for in vitro protein binding in plasma equivalent to those determined by ultrafiltration. Microdialysis offers advantages in terms of maintaining equilibria and experimental versatility. Microdialysis sampling also provides potential use for in vivo determinations of protein binding.

Mesh:

Substances:

Year:  1990        PMID: 2281040     DOI: 10.1023/a:1015955503708

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects.

Authors:  H G Boxenbaum; I Berkersky; V Mattaliano; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  In vivo microdialysis sampling coupled to liquid chromatography for the study of acetaminophen metabolism.

Authors:  D O Scott; L R Sorensen; C E Lunte
Journal:  J Chromatogr       Date:  1990-05-11

3.  Rapid determination of the concentration of unbound warfarin in human plasma.

Authors:  K A Bachmann
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-10

4.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07

5.  The binding of paracetamol to plasma proteins of man and pig.

Authors:  B G Gazzard; A W Ford-Hutchinson; M J Smith; R Williams
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

6.  Ultrafiltration in serum protein binding determinations.

Authors:  J B Whitlam; K F Brown
Journal:  J Pharm Sci       Date:  1981-02       Impact factor: 3.534

7.  Human serum protein binding of cephalosporin antibiotics in vitro.

Authors:  S M Singhvi; A F Heald; H H Gadebusch; M E Resnick; L T Difazio; M A Leitz
Journal:  J Lab Clin Med       Date:  1977-02

8.  Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.

Authors:  A Yacobi; J A Udall; G Levy
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

9.  An improved ultrafiltration method for free thyroxine and triiodothyronine in serum.

Authors:  J Sophianopoulos; I Jerkunica; C N Lee; D Sgoutas
Journal:  Clin Chem       Date:  1980-01       Impact factor: 8.327

10.  Chloramphenicol pharmacokinetics in hospitalized patients.

Authors:  J R Koup; A H Lau; B Brodsky; R L Slaughter
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

View more
  21 in total

1.  Pharmacokinetic estimations from microdialysis data.

Authors:  L Ståhle
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  In vivo microdialysis sampling for pharmacokinetic investigations.

Authors:  D O Scott; L R Sorenson; K L Steele; D L Puckett; C E Lunte
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

3.  The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion.

Authors:  Peng-Fei Yue; Xiu-Yun Lu; Zeng-Zhu Zhang; Hai-Long Yuan; Wei-Feng Zhu; Qin Zheng; Ming Yang
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

4.  Effect of protein binding on the pharmacological activity of highly bound antibiotics.

Authors:  Stephan Schmidt; Katharina Röck; Martina Sahre; Olaf Burkhardt; Martin Brunner; Maximilian T Lobmeyer; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2008-09-08       Impact factor: 5.191

Review 5.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 6.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

7.  The binding of cyclosporin A to human plasma: an in vitro microdialysis study.

Authors:  H Yang; W F Elmquist
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

8.  Quantitative microdialysis for studying the in vivo L-DOPA kinetics in blood and skeletal muscle of the dog.

Authors:  S Sarre; D Deleu; K Van Belle; G Ebinger; Y Michotte
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

9.  Evaluation of methotrexate tissue exposure by in situ microdialysis in a rat model.

Authors:  O Ekstrøm; A Andersen; D J Warren; K E Giercksky; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Development of a dog microdialysis model for determining synovial fluid pharmacokinetics of anti-arthritis compounds exemplified by methotrexate.

Authors:  Mingxin Qian; Wanda West; Jing-Tao Wu; Bing Lu; David D Christ
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.